Cargando…

A qualitative investigation into the impact of hemophagocytic lymphohistiocytosis on children and their caregivers

BACKGROUND: Primary hemophagocytic lymphohistiocytosis (pHLH) is a rare and life-threatening disorder, which usually occurs during infancy or early childhood and is characterized by abnormal activation of the immune system. However, the burden of pHLH on children and their families has not been prev...

Descripción completa

Detalles Bibliográficos
Autores principales: Nixon, Annabel, Roddick, Elina, Moore, Karen, Wild, Diane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8101208/
https://www.ncbi.nlm.nih.gov/pubmed/33957935
http://dx.doi.org/10.1186/s13023-021-01832-2
_version_ 1783688925265526784
author Nixon, Annabel
Roddick, Elina
Moore, Karen
Wild, Diane
author_facet Nixon, Annabel
Roddick, Elina
Moore, Karen
Wild, Diane
author_sort Nixon, Annabel
collection PubMed
description BACKGROUND: Primary hemophagocytic lymphohistiocytosis (pHLH) is a rare and life-threatening disorder, which usually occurs during infancy or early childhood and is characterized by abnormal activation of the immune system. However, the burden of pHLH on children and their families has not been previously evaluated. This qualitative study investigated the impact of pHLH and its treatment on the physical, emotional, and social well-being of patients and caregivers in the USA and UK using interviews to provide a comprehensive insight from the perspective of the caregivers and young survivors. RESULTS: Twenty-one caregivers were enrolled (median [range] age, 41.1 [26–58] years) and represented 20 patients, four from the UK and 16 from the USA. At enrollment, 17 of the 20 patients were alive with a median [range] age of 12.75 [5–31] years at a mean [range] of 7.8 [0.6–11.6] years after diagnosis. In addition, four adult survivors (median [range] age, 23.3 [21–30] years) were also enrolled (total participants n = 25). From noticing initial symptoms to receiving a diagnosis, caregivers reported a mean (range) of 25.9 (0–258) months. pHLH and its treatment had a substantial and long-lasting impact on patients and caregivers, affecting their physical, emotional and social well-being, family relationships, friendships, and ability to work and study. Many of the experiences reported were negative, even after curative treatment, and some participants experienced long-lasting physical and emotional issues. The most noticeable impact of pHLH for patients was on their physical well-being, whereas for caregivers it was emotional well-being. Across all participants there was a sense of isolation due to the illness and its treatment, particularly regarding the patient being immunocompromised and the fear of infection. Areas having a major impact and considered in need of improvement included: delays in diagnosis, lack of patient-specific information on pHLH and a lack of support and understanding about the condition. CONCLUSIONS: pHLH placed a substantial burden on patients and caregivers, which for some were long-lasting. This was compounded by the lack of awareness and understanding of pHLH by healthcare professionals, and a lack of accessible information for those affected by pHLH. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13023-021-01832-2.
format Online
Article
Text
id pubmed-8101208
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-81012082021-05-06 A qualitative investigation into the impact of hemophagocytic lymphohistiocytosis on children and their caregivers Nixon, Annabel Roddick, Elina Moore, Karen Wild, Diane Orphanet J Rare Dis Research BACKGROUND: Primary hemophagocytic lymphohistiocytosis (pHLH) is a rare and life-threatening disorder, which usually occurs during infancy or early childhood and is characterized by abnormal activation of the immune system. However, the burden of pHLH on children and their families has not been previously evaluated. This qualitative study investigated the impact of pHLH and its treatment on the physical, emotional, and social well-being of patients and caregivers in the USA and UK using interviews to provide a comprehensive insight from the perspective of the caregivers and young survivors. RESULTS: Twenty-one caregivers were enrolled (median [range] age, 41.1 [26–58] years) and represented 20 patients, four from the UK and 16 from the USA. At enrollment, 17 of the 20 patients were alive with a median [range] age of 12.75 [5–31] years at a mean [range] of 7.8 [0.6–11.6] years after diagnosis. In addition, four adult survivors (median [range] age, 23.3 [21–30] years) were also enrolled (total participants n = 25). From noticing initial symptoms to receiving a diagnosis, caregivers reported a mean (range) of 25.9 (0–258) months. pHLH and its treatment had a substantial and long-lasting impact on patients and caregivers, affecting their physical, emotional and social well-being, family relationships, friendships, and ability to work and study. Many of the experiences reported were negative, even after curative treatment, and some participants experienced long-lasting physical and emotional issues. The most noticeable impact of pHLH for patients was on their physical well-being, whereas for caregivers it was emotional well-being. Across all participants there was a sense of isolation due to the illness and its treatment, particularly regarding the patient being immunocompromised and the fear of infection. Areas having a major impact and considered in need of improvement included: delays in diagnosis, lack of patient-specific information on pHLH and a lack of support and understanding about the condition. CONCLUSIONS: pHLH placed a substantial burden on patients and caregivers, which for some were long-lasting. This was compounded by the lack of awareness and understanding of pHLH by healthcare professionals, and a lack of accessible information for those affected by pHLH. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13023-021-01832-2. BioMed Central 2021-05-06 /pmc/articles/PMC8101208/ /pubmed/33957935 http://dx.doi.org/10.1186/s13023-021-01832-2 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Nixon, Annabel
Roddick, Elina
Moore, Karen
Wild, Diane
A qualitative investigation into the impact of hemophagocytic lymphohistiocytosis on children and their caregivers
title A qualitative investigation into the impact of hemophagocytic lymphohistiocytosis on children and their caregivers
title_full A qualitative investigation into the impact of hemophagocytic lymphohistiocytosis on children and their caregivers
title_fullStr A qualitative investigation into the impact of hemophagocytic lymphohistiocytosis on children and their caregivers
title_full_unstemmed A qualitative investigation into the impact of hemophagocytic lymphohistiocytosis on children and their caregivers
title_short A qualitative investigation into the impact of hemophagocytic lymphohistiocytosis on children and their caregivers
title_sort qualitative investigation into the impact of hemophagocytic lymphohistiocytosis on children and their caregivers
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8101208/
https://www.ncbi.nlm.nih.gov/pubmed/33957935
http://dx.doi.org/10.1186/s13023-021-01832-2
work_keys_str_mv AT nixonannabel aqualitativeinvestigationintotheimpactofhemophagocyticlymphohistiocytosisonchildrenandtheircaregivers
AT roddickelina aqualitativeinvestigationintotheimpactofhemophagocyticlymphohistiocytosisonchildrenandtheircaregivers
AT moorekaren aqualitativeinvestigationintotheimpactofhemophagocyticlymphohistiocytosisonchildrenandtheircaregivers
AT wilddiane aqualitativeinvestigationintotheimpactofhemophagocyticlymphohistiocytosisonchildrenandtheircaregivers
AT nixonannabel qualitativeinvestigationintotheimpactofhemophagocyticlymphohistiocytosisonchildrenandtheircaregivers
AT roddickelina qualitativeinvestigationintotheimpactofhemophagocyticlymphohistiocytosisonchildrenandtheircaregivers
AT moorekaren qualitativeinvestigationintotheimpactofhemophagocyticlymphohistiocytosisonchildrenandtheircaregivers
AT wilddiane qualitativeinvestigationintotheimpactofhemophagocyticlymphohistiocytosisonchildrenandtheircaregivers